Imerys Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Imerys de 44.3% y 3.5% por año respectivamente. Se prevé que el BPA crezca en un 46.9% al año. Se espera que la rentabilidad financiera sea de 10.6% en 3 años.

Información clave

50.4%

Tasa de crecimiento de los beneficios

48.8%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Basic Materials	8.1%
Tasa de crecimiento de los ingresos	3.8%
Rentabilidad financiera futura	11.8%
Cobertura de analistas	Low
Última actualización	02 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Can Imerys S.A.'s (EPA:NK) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?

Feb 09

What Kind Of Investors Own Most Of Imerys S.A. (EPA:NK)?

Jan 18

Previsiones de crecimiento de beneficios e ingresos

ENXTPA:NK - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	4,074	359	221	N/A	3
12/31/2025	3,941	306	131	N/A	4
12/31/2024	3,815	265	193	N/A	5
3/31/2024	3,723	15	N/A	N/A	N/A
12/31/2023	3,794	8	205	603	N/A
9/30/2023	3,924	189	N/A	N/A	N/A
6/30/2023	4,122	126	146	533	N/A
3/31/2023	4,266	177	N/A	N/A	N/A
12/31/2022	4,282	173	62	452	N/A
9/30/2022	4,904	191	N/A	N/A	N/A
6/30/2022	3,648	187	145	534	N/A
3/31/2022	4,535	241	N/A	N/A	N/A
12/31/2021	3,665	181	182	543	N/A
9/30/2021	4,249	151	N/A	N/A	N/A
6/30/2021	4,057	115	233	502	N/A
3/31/2021	3,829	58	N/A	N/A	N/A
12/31/2020	3,799	30	284	538	N/A
9/30/2020	3,822	56	N/A	N/A	N/A
6/30/2020	3,991	82	304	609	N/A
3/31/2020	4,259	98	N/A	N/A	N/A
12/31/2019	4,355	121	203	516	N/A
9/30/2019	4,485	-35	N/A	N/A	N/A
6/30/2019	4,543	-294	189	473	N/A
3/31/2019	4,584	-235	N/A	N/A	N/A
12/31/2018	4,590	-228	280	616	N/A
9/30/2018	4,356	0	N/A	N/A	N/A
6/30/2018	4,545	324	353	688	N/A
3/31/2018	4,693	381	N/A	N/A	N/A
12/31/2017	4,299	301	N/A	622	N/A
9/30/2017	4,432	342	N/A	N/A	N/A
6/30/2017	4,133	273	N/A	614	N/A
3/31/2017	4,240	299	N/A	N/A	N/A
12/31/2016	4,165	293	N/A	634	N/A
9/30/2016	4,129	69	N/A	N/A	N/A
6/30/2016	4,126	81	N/A	557	N/A
3/31/2016	4,151	72	N/A	N/A	N/A
12/31/2015	4,087	68	N/A	545	N/A
9/30/2015	3,991	284	N/A	N/A	N/A
6/30/2015	3,908	285	N/A	480	N/A
3/31/2015	3,758	263	N/A	N/A	N/A
12/31/2014	3,688	272	N/A	417	N/A
9/30/2014	3,673	249	N/A	N/A	N/A
6/30/2014	3,655	245	N/A	448	N/A
3/31/2014	3,672	250	N/A	N/A	N/A
12/31/2013	3,698	242	N/A	463	N/A
9/30/2013	3,721	267	N/A	N/A	N/A
6/30/2013	3,779	263	N/A	445	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (44.3% al año) de NK es superior a la tasa de ahorro (1%).

Beneficios vs. Mercado: Se prevé que los beneficios (44.3% al año) de NK crezcan más rápidamente que el mercado French (10.7% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de NK crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (3.5% al año) de NK crezcan más despacio que el mercado de French (5.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 3.5% al año) de NK crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de NK sea baja dentro de 3 años (10.6%).

Imerys Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 7.1% to €45.00

Consensus EPS estimates increase by 12%

Price target decreased by 7.1% to €42.00

Consensus EPS estimates fall by 18%, revenue upgraded

Price target increased to €51.40

Price target increased to €51.40

Recent updates

Imerys S.A. to Report Q2, 2024 Results on Jul 29, 2024

First quarter 2024 earnings released

Is Imerys (EPA:NK) Using Too Much Debt?

Estimating The Fair Value Of Imerys S.A. (EPA:NK)

Imerys Enters into Exclusive Negotiations for the Sale of its Assets Serving the Paper Market

Price target increased by 7.1% to €45.00

Full year 2023 earnings: EPS and revenues miss analyst expectations

Imerys S.A.'s (EPA:NK) Shares Climb 27% But Its Business Is Yet to Catch Up

Should You Investigate Imerys S.A. (EPA:NK) At €31.14?

Mytilineos S.A. (ATSE:MYTIL) acquired IMERYS Greece Bauxite from Imerys S.A. (ENXTPA:NK).

Investor sentiment improves as stock rises 23%

Now 33% overvalued after recent price rise

Consensus EPS estimates increase by 12%

Are Imerys S.A. (EPA:NK) Investors Paying Above The Intrinsic Value?

Imerys S.A. to Report Q1, 2024 Results on Apr 30, 2024

Imerys (EPA:NK) Takes On Some Risk With Its Use Of Debt

Price target decreased by 7.1% to €42.00

Imerys (EPA:NK) May Have Issues Allocating Its Capital

Imerys S.A. to Report Fiscal Year 2023 Results on Feb 21, 2024

When Should You Buy Imerys S.A. (EPA:NK)?

Calculating The Intrinsic Value Of Imerys S.A. (EPA:NK)

Mytilineos S.A. (ATSE:MYTIL) signed an agreement to acquire IMERYS Greece Bauxite from Imerys S.A. (ENXTPA:NK) for €10 million.

Mytilineos is in Advanced Negotiations to Acquire Imerys Bauxite Greece

Does Imerys (EPA:NK) Have A Healthy Balance Sheet?

Consensus EPS estimates fall by 18%, revenue upgraded

Imerys (EPA:NK) Will Be Looking To Turn Around Its Returns

New minor risk - Profit margin trend

Second quarter 2023 earnings released

Should You Think About Buying Imerys S.A. (EPA:NK) Now?

Imerys S.A. (EPA:NK) Shares Could Be 25% Above Their Intrinsic Value Estimate

Upcoming dividend of €3.85 per share at 4.3% yield

First quarter 2023 earnings released: EPS: €0.73 (vs €0.86 in 1Q 2022)

At €38.18, Is It Time To Put Imerys S.A. (EPA:NK) On Your Watch List?

These 4 Measures Indicate That Imerys (EPA:NK) Is Using Debt Extensively

Full year 2022 earnings: EPS and revenues miss analyst expectations

Imerys S.A. to Report Q1, 2023 Results on May 02, 2023

Platinum Equity, LLC acquired High Temperature Solutions Business of Imerys S.A. from Imerys S.A. (ENXTPA:NK) in a transaction valued at approximately €930 million.

Platinum Equity, LLC acquired High Temperature Solutions Business of Imerys S.A. from Imerys S.A. (ENXTPA:NK) for approximately €930 million.

Should You Be Adding Imerys (EPA:NK) To Your Watchlist Today?

Should You Investigate Imerys S.A. (EPA:NK) At €37.66?

Price target increased to €51.40

High number of new directors

Third quarter 2022 earnings released

Imerys S.A. to Report Fiscal Year 2022 Results on Feb 16, 2023

Price target increased to €51.40

Price target increased to €47.00

Estimating The Intrinsic Value Of Imerys S.A. (EPA:NK)

Is Imerys (EPA:NK) A Risky Investment?

Platinum Equity Advisors, LLC acquired CALDERYS France S.A.S. from Imerys S.A. (ENXTPA:NK).

Imerys S.A. Announces Executive Appointments

CIMBAR Performance Minerals, Inc. acquired Sahuarita Arizona operation of Imerys.

What Does Imerys S.A.'s (EPA:NK) Share Price Indicate?

Imerys Introduces ImerShield Solutions

Second quarter 2022 earnings released: EPS: €1.41 (vs €0.82 in 2Q 2021)

An Intrinsic Calculation For Imerys S.A. (EPA:NK) Suggests It's 28% Undervalued

These 4 Measures Indicate That Imerys (EPA:NK) Is Using Debt Reasonably Well

High number of new directors

Upcoming dividend of €1.55 per share

Northern Graphite Corporation (TSXV:NGC) completed the acquisition of Okanjande graphite deposit in Namibia from Imerys S.A. (ENXTPA:NK).

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Is Imerys S.A. (EPA:NK) Trading At A 24% Discount?

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates increase by 11%

At €39.94, Is Imerys S.A. (EPA:NK) Worth Looking At Closely?

Is Imerys (EPA:NK) A Risky Investment?

Is Now The Time To Put Imerys (EPA:NK) On Your Watchlist?

Third quarter 2021 earnings released: EPS €0.89 (vs €0.48 in 3Q 2020)

Here's Why Imerys (EPA:NK) Can Manage Its Debt Responsibly

Imerys S.A. (ENXTPA:NK) commences an Equity Buyback Plan for 8,494,095 shares, representing 10% of its issued share capital, under the authorization approved on May 10, 2021.